{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T20:12:10Z","timestamp":1779826330187,"version":"3.53.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.farma.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:30:33Z","timestamp":1778815833000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estandarizaci\u00f3n de la preparaci\u00f3n de antimicrobianos intravenosos ready-to-use en una unidad de hospitalizaci\u00f3n a domicilio pedi\u00e1trica"],"prefix":"10.1016","author":[{"given":"Alejandra","family":"Merino-Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Algarra S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Hern\u00e1ndez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fern\u00e1ndez-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Cuervas-Mons Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107263","article-title":"Safety and efficacy of outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis of randomized clinical trials","volume":"64","author":"Mohammed","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.farma.2026.04.005_bb0010","series-title":"Norma Para la certificaci\u00f3n de los Equipos PROA Hospitalarios","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2023"},{"issue":"5","key":"10.1016\/j.farma.2026.04.005_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.anpedi.2023.08.002","article-title":"La hospitalizaci\u00f3n domiciliaria del paciente Agudo: un nuevo enfoque de cuidados","volume":"99","author":"Batlle","year":"2023","journal-title":"An Pediatr"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jacamr\/dlaf075","article-title":"Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey","volume":"7","author":"Wolie","year":"2025","journal-title":"JAC Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/archdischild-2019-317629","article-title":"Being \u2018at-home\u2019 on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents\u2019 experiences of paediatric OPAT","volume":"105","author":"Carter","year":"2020","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.farma.2026.04.005_bb0030","series-title":"Gu\u00eda de buenas pr\u00e1cticas de preparaci\u00f3n de medicamentos en servicios de farmacia hospitalaria","author":"Ministerio de Sanidad","year":"2024"},{"key":"10.1016\/j.farma.2026.04.005_bb0035","series-title":"Seguridad cl\u00ednica y farmacia hospitalaria: documento de posicionamiento sobre trazabilidad y uso seguro del medicamento en hospitales","author":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria","year":"2022"},{"issue":"19","key":"10.1016\/j.farma.2026.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/ajhp\/zxac167","article-title":"Impact of technology-assisted versus manual sterile compounding on safety and efficiency in a Canadian community hospital","volume":"79","author":"Fan","year":"2022","journal-title":"Am J Health-Syst Pharm"},{"issue":"6","key":"10.1016\/j.farma.2026.04.005_bb0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.farma.2024.03.005","article-title":"Implantaci\u00f3n de un sistema de trazabilidad y elaboraci\u00f3n segura de medicamentos en la sala blanca","volume":"48","author":"Ech\u00e1varri de Miguel","year":"2024","journal-title":"Farm Hosp"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ejhpharm-2022-003316","article-title":"Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients","volume":"31","author":"Taladriz-Sender","year":"2024","journal-title":"Eur J Hosp Pharm"},{"issue":"6","key":"10.1016\/j.farma.2026.04.005_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ajhp\/55.6.574","article-title":"Stability of acyclovir sodium 1, 7, and 10 mg\/mL in 5% dextrose injection and 0.9% sodium chloride injection","volume":"55","author":"Zhang","year":"1998","journal-title":"Am J Health-Syst Pharm"},{"issue":"9","key":"10.1016\/j.farma.2026.04.005_bb0060","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajhp\/zxab071","article-title":"Long-term physicochemical stability of acyclovir 5\u202fmg\/mL solution stored in polypropylene bags as a simulated hospital stock preparation","volume":"78","author":"Legeron","year":"2021","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0065","first-page":"230","article-title":"Stability of amikacin sulfate in autodose infusion system bags","volume":"7","author":"Zhang","year":"2003","journal-title":"Int J Pharm Compd"},{"key":"10.1016\/j.farma.2026.04.005_bb0070","first-page":"106","article-title":"The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (freeflex container)","volume":"6","author":"M\u00fcller","year":"2003","journal-title":"Eur J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0075","first-page":"226","article-title":"Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose infusion system bags","volume":"6","author":"Zhang","year":"2002","journal-title":"Int J Pharm Compd"},{"issue":"4","key":"10.1016\/j.farma.2026.04.005_bb0080","first-page":"338","article-title":"Stability of ampicillin in normal saline and buffered normal saline","volume":"20","author":"Maher","year":"2016","journal-title":"Int J Pharm Compd"},{"issue":"8","key":"10.1016\/j.farma.2026.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics15082099","article-title":"Ampicillin stability in a portable elastomeric infusion pump: a step forward in outpatient parenteral antimicrobial therapy","volume":"15","author":"Rodr\u00edguez-Mart\u00ednez","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0090","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/antibiotics12030432","article-title":"Stability of ampicillin plus ceftriaxone combined in elastomeric infusion devices for outpatient parenteral antimicrobial therapy","volume":"12","author":"Fern\u00e1ndez-Rubio","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1331\/108658002763316851","article-title":"Stability of three cephalosporin antibiotics in autodose infusion system bags","volume":"42","author":"Xu","year":"2002","journal-title":"J Am Pharm Assoc (Wash)"},{"issue":"4","key":"10.1016\/j.farma.2026.04.005_bb0100","first-page":"241","article-title":"Stability of cefazolin sodium in polypropylene syringes and polyvinylchloride minibags","volume":"64","author":"Donnelly","year":"2011","journal-title":"Can J Hosp Pharm"},{"issue":"6","key":"10.1016\/j.farma.2026.04.005_bb0105","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1345\/aph.1C313","article-title":"Stability of cefepime hydrochloride in autodose infusion system bags","volume":"37","author":"Trissel","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0110","first-page":"166","article-title":"Stability of low-concentration ceftazidime in 0.9% sodium chloride injection and balanced salt solutions in plastic syringes under various storage conditions","volume":"13","author":"Xu","year":"2009","journal-title":"Int J Pharm Compd"},{"issue":"7","key":"10.1016\/j.farma.2026.04.005_bb0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ajhp\/55.7.683","article-title":"Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device","volume":"55","author":"Stendal","year":"1998","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0120","first-page":"24","article-title":"Reconstitution stability of ceftriaxone sodium for injection in intravenous diluents","volume":"1","author":"Tippa","year":"2021","journal-title":"Der Pharmacia Sinica"},{"issue":"1","key":"10.1016\/j.farma.2026.04.005_bb0125","first-page":"47","article-title":"Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures","volume":"11","author":"Gupta","year":"1986","journal-title":"J Clin Hosp Pharm"},{"issue":"1","key":"10.1016\/j.farma.2026.04.005_bb0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/03639045.2015.1038273","article-title":"Stability of 10\u202fmg\/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method","volume":"42","author":"Feutry","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1016\/j.farma.2026.04.005_bb0135","first-page":"310","article-title":"Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use","volume":"7","author":"Gupta","year":"2003","journal-title":"Int J Pharm Compd"},{"issue":"19","key":"10.1016\/j.farma.2026.04.005_bb0140","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/ajhp\/54.19.2204","article-title":"Stability of cidofovir in 0.9% sodium chloride injection for five days","volume":"54","author":"Ennis","year":"1997","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0145","first-page":"149","article-title":"Stability of clindamycin phosphate in autodose infusion system bags","volume":"7","author":"Xu","year":"2003","journal-title":"Int J Pharm Compd"},{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/1078155217732629","article-title":"Long-term stability of ganciclovir in polypropylene containers at room temperature","volume":"25","author":"Guichard","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/001857870303800212","article-title":"Stability of Imipenem-cilastatin sodium in autodose infusion system bags","volume":"38","author":"Trissel","year":"2003","journal-title":"Hosp Pharm"},{"issue":"4","key":"10.1016\/j.farma.2026.04.005_bb0160","article-title":"Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride","volume":"51","author":"Walker","year":"2018","journal-title":"Can J Hosp Pharm"},{"issue":"16","key":"10.1016\/j.farma.2026.04.005_bb0165","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ajhp\/61.16.1682","article-title":"Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device","volume":"61","author":"Smith","year":"2004","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4212\/cjhp.v62i3.792","article-title":"Stability of aseptically prepared tazocin solutions in polyvinyl chloride bags","volume":"62","author":"Donnelly","year":"2009","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.farma.2026.04.005_bb0175","series-title":"ASHP injectable drug information. A comprehensive guide to compatibility and stability","author":"American Society of Health-System Pharmacists","year":"2023"},{"issue":"9","key":"10.1016\/j.farma.2026.04.005_bb0180","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/ajhp\/54.9.1068","article-title":"Stability of nafcillin sodium, oxacillin sodium, penicillin g potassium, penicillin g sodium, and tobramycin sulfate in polyvinyl chloride drug reservoirs","volume":"54","author":"Stiles","year":"1997","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"10.1016\/j.farma.2026.04.005_bb0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0148607192016003268","article-title":"Vancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infections","volume":"16","author":"Yao","year":"1992","journal-title":"J Parenter Enteral Nutr"},{"issue":"6","key":"10.1016\/j.farma.2026.04.005_bb0190","first-page":"135","article-title":"Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care","volume":"12","author":"Griffiths","year":"2006","journal-title":"Eur J Hosp Pharm Sci"},{"issue":"6","key":"10.1016\/j.farma.2026.04.005_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eimc.2018.03.012","article-title":"Executive summary of outpatient parenteral antimicrobial therapy: guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society","volume":"37","author":"L\u00f3pez Cort\u00e9s","year":"2019","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"6","key":"10.1016\/j.farma.2026.04.005_bb0200","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s15010-025-02619-4","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy (OPAT) in Germany","volume":"53","author":"Tometten","year":"2025","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.farma.2026.04.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlz026","article-title":"Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK","volume":"1","author":"Chapman","year":"2019","journal-title":"JAC Antimicrob Resist"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:57:19Z","timestamp":1779825439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"alternative-id":["S1130634326000796"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.005","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estandarizaci\u00f3n de la preparaci\u00f3n de antimicrobianos intravenosos ready-to-use en una unidad de hospitalizaci\u00f3n a domicilio pedi\u00e1trica","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}